FDA Adverse Event Malfunction Summary report: N

LEAD MODEL 304

MDR report key: 21389438 · Received February 14, 2025

Report

Report Number
1644487-2025-00163
Event Type
Malfunction
Date Received
February 14, 2025
Date of Event
December 10, 2024
Report Date
February 14, 2025
Manufacturer
CYBERONICS - HOUSTON
Product Code
LYJ
PMA / PMN Number
P970003
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

LIVANOVA USA, INC. SUBMITS THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION, BASED ON INFORMATION THAT LIVANOVA HAS OBTAINED, BUT MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION, OR A CONCLUSION BY FDA OR ANYONE ELSE, THAT THE DEVICE, LIVANOVA, OR LIVANOVA'S EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS¿ OR "MALFUNCTIONS¿. THESE WORDS ARE INCORPORATED INTO THE FDA 3500A MEDWATCH FORM BY THE FDA, AND LIVANOVA OBJECTS TO THEIR USE.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING IMPLANT, THE ANCHOR TETHER HELIX WAS NOT FULLY SEPARATED AND IT COULD NOT PROPERLY STRETCH TO COIL AROUND NERVE. PER THE REPORT, THE TOP COIL OF THE ANCHOR TETHER'S HELIX WAS SLIGHTLY ADHERED TO THE CENTER COIL, BUT THE SURGEON WAS ABLE TO SEPARATE THE TETHER HELIX WITH MANIPULATION, AND THE LEAD WAS SUCCESSFULLY IMPLANTED, WITH THE LEAD LOOKING NORMAL. A REVIEW OF DEVICE HISTORY RECORDS SHOWED THAT THE LEAD PASSED QUALITY CONTROL INSPECTION PRIOR TO DISTRIBUTION. NO SURGICAL INTERVENTION HAS BEEN REPORTED TO DATE. NO ADDITIONAL RELEVANT INFORMATION HAS BEEN RECEIVED TO DATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1152105 LEAD MODEL 304 LEAD LYJ CYBERONICS - HOUSTON 304-20 7922

Patients

Seq Age Sex Outcome Treatment
1 31 MO Male